Multicenter Open Label Phase 2 Study of Quadruplet-Based Regimen Iskpd (isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib) in Early Relapsed or Refractory Multiple Myeloma - IFM2018-03
BLOOD(2023)
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined